Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous haloperidol versus intravenous acetaminophen for primary headache in the emergency department
IRCT20190820044569N1Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Primary headache disorder comparing Intravenous haloperidol with Intravenous acetaminophen (2 arms). Primary endpoints: Reduce headache, Length of stay in the emergency room and 1 more. Started Jul 2022; status: completed.
02
Drugs
haloperidolacetaminophen
03
Conditions
Primary headache disorder
Beyond the preview
Go deeper on IRCT20190820044569N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190820044569N1.